» Articles » PMID: 39997390

Comprehensive Review of Environmental Surveillance for Azole-Resistant : A Practical Roadmap for Hospital Clinicians and Infection Control Teams

Overview
Journal J Fungi (Basel)
Date 2025 Feb 25
PMID 39997390
Authors
Affiliations
Soon will be listed here.
Abstract

As azole-resistant emerges globally, healthcare facilities face mounting challenges in managing invasive aspergillosis. This review synthesizes worldwide azole resistance data to reveal profound regional variability, demonstrating that findings from other regions cannot be directly extrapolated to local settings. Consequently, hospital-level environmental surveillance is crucial for tailoring interventions to local epidemiology and detecting resistant strains in real-time. We outline practical approaches-encompassing sampling site prioritization, diagnostic workflows (culture-based and molecular), and PDCA-driven continuous improvement-so that even resource-limited facilities can manage resistant isolates more effectively. By linking real-time surveillance findings with clinical decisions, hospitals can tailor antifungal stewardship programs and swiftly adjust prophylaxis or treatment regimens. Our approach aims to enable accurate, ongoing evaluations of emerging resistance patterns, ensuring that institutions maintain efficient and adaptive programs. Ultimately, we advocate for sustained, collaborative efforts worldwide, where facilities adapt protocols to local conditions, share data through international networks, and contribute to a global knowledge base on resistance mechanisms. Through consistent application of these recommendations, healthcare systems can better preserve azole efficacy, safeguard immunocompromised populations, and refine infection control practices in the face of evolving challenges.

References
1.
Lestrade P, van der Velden W, Bouwman F, Stoop F, Blijlevens N, Melchers W . Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study. J Antimicrob Chemother. 2018; 73(5):1389-1394. DOI: 10.1093/jac/dkx527. View

2.
Talbot J, Subedi S, Halliday C, Hibbs D, Lai F, Lopez-Ruiz F . Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates. J Antimicrob Chemother. 2018; 73(9):2347-2351. DOI: 10.1093/jac/dky187. View

3.
Tsuchido Y, Tanaka M, Nakano S, Yamamoto M, Matsumura Y, Nagao M . Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan. Med Mycol. 2019; 57(8):997-1003. DOI: 10.1093/mmy/myz003. View

4.
Debergh H, Haesendonck R, Botteldoorn N, Martel A, Pasmans F, Saegerman C . Pan-azole resistance in clinical isolates carrying TR34/L98H from birds and mammals in Belgium. One Health. 2024; 19:100907. PMC: 11490837. DOI: 10.1016/j.onehlt.2024.100907. View

5.
van Paassen J, Russcher A, In t Veld-van Wingerden A, Verweij P, Kuijper E . Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. Euro Surveill. 2016; 21(30). DOI: 10.2807/1560-7917.ES.2016.21.30.30300. View